Inform real-world substance use interventions through health economics research
Explore our core disciplines in economic evaluation methods, population data, simulation modeling, and dissemination science.
Eligible researchers can receive up to six hours of consultation at no cost on how to incorporate economic analyses into a study.
Through CHERISH pilot grants, we support early-career researchers and trainees become proficient with health economic methods and lead innovative economic studies.
Tools & Resources
We curate health economic tools, training, and resources for researchers to use in their study.
CHERISH brings together leading experts from five institutions
Established in 2015, CHERISH is funded by the National Institute on Drug Abuse (NIDA) as a Center of Excellence. CHERISH is a collaboration among Weill Cornell Medicine, Boston Medical Center, Boston University School of Public Health, University of Pennsylvania, and University of Miami Miller School of Medicine (P30DA040500).
News & Events
Penn LDI & CHERISH Launch New Online Communications Training Course for Academic Researchers
The University of Pennsylvania’s Leonard Davis Institute of Health Economics (LDI), which since 2019 has been offering the [email protected] in-person communications course to help academic researchers translate and disseminate their findings more widely, has developed and just launched a free, online course providing an introduction to the same topics. The new training resource is a […]
Dr. Yuhua Bao Receives Grants to Study Implications of Opioid and Other Drug Policies on People with Cancer
Dr. Yuhua Bao, professor of population health sciences in the Division of Health Policy and Economics, has received grants from the American Cancer Society (ACS) and the National Cancer Institute (NCI) to assess the implications of opioid and other drug policies for patients receiving active cancer treatments, long-term survivors of cancer, and cancer patients with advanced disease. “Both studies are motivated by the […]
Sean M. Murphy and Chelsea L. Shover Receive Inaugural NIH HEAL Director’s Award and Trailblazer Award
The 4th Annual NIH Helping to End Addiction Long-Term (HEAL) Initiative Investigator Meeting took place on February 22, 2023. HEAL-funded investigators and key stakeholders gathered in Bethesda, MD, to share research findings and identify new opportunities for pain and opioid use disorder research. HEAL Director Dr. Rebecca Baker also presented the inaugural NIH HEAL Initiative Director’s Awards for […]
Will States and Counties Spend Their National Opioid Settlements Effectively?
As $54 billion in National Opioid Settlement funds begin moving out toward states, counties, and municipalities, there is widespread concern among health authorities that the legal victory does not become a repeat of the 1998 mega-billion-dollar Tobacco Master Settlement Agreement fiasco in which most states used the money for just about everything except tobacco cessation […]
New Federal Rules That Lower Barriers to Opioid Care Could Save Thousands of Lives
The two main medications that treat opioid use in the United States reduce overdose deaths by 50%. Yet fewer than one in 10 people with opioid use disorder (OUD) can access this kind of medical protocol, according to the Centers for Disease Control and Prevention (CDC). Fortunately, a new law and a new federal regulation […]
Budget Impact Tool for the Incorporation of Medications for Opioid Use Disorder into Jail/Prison Facilities
Despite evidence that medications for opioid use disorder (MOUD), namely methadone, buprenorphine, and naltrexone, provided at the point of incarceration improve the well-being of the individual and the public, financial and administrative limitations in jail/prison healthcare often serve as barriers to this recommended first-line treatment for OUD. In fact, evidence indicates that more than 80% […]
Catching Up with Pilot Grant Recipient: Rachel Epstein
Rachel Epstein is a clinician-scientist with demonstrated experience in analyzing large datasets to inform hepatitis C (HCV), HIV, and substance use disorder interventions. A CHERISH pilot grantee in 2019, she worked closely with her co-investigators Benjamin Linas, CHERISH Population Data and Modeling Core director, and Shashi Kapadia, a CHERISH Research Affiliate and an infectious diseases physician at Weill […]
Addressing Statistical Issues Encountered in Conducting Prospective Economic Evaluations Alongside Clinical Trials
Methods to address missingness and sampling uncertainty in an economic evaluation are not independent of one another. Determining the most appropriate combination of methods poses unique statistical and practical challenges for researchers, requiring careful consideration of the missing data mechanism, computation resources, and a variety of other potential factors such as the proportion of missingness […]
Stay connected with CHERISH
Three times a year, we deliver our latest news and research, and highlight opportunities to engage in health economics, substance use, HCV, and HIV research.